{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:07:45Z","timestamp":1790222865192,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100019009","name":"Fondation Francophone pour la Recherche sur le Diab\u00e8te","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jcf.2025.11.003","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T12:34:24Z","timestamp":1763642064000},"page":"328-335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Continuous glucose monitoring is a better indicator of glucose tolerance than HbA1c in cystic fibrosis"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4549-699X","authenticated-orcid":false,"given":"Laure","family":"Alexandre-Heymann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quitterie","family":"Reynaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1728-6749","authenticated-orcid":false,"given":"Caroline","family":"Grou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1198-3287","authenticated-orcid":false,"given":"Val\u00e9rie","family":"Boudreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Parent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Rakotoarisoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1364-7855","authenticated-orcid":false,"given":"Heather","family":"Girouard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Durieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Kessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ad\u00e8le","family":"Coriati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2025.11.003_bib0001","first-page":"3","article-title":"Cystic fibrosis-related diabetes: clinical approach and knowledge gaps","volume":"46","author":"Prentice","year":"2023","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.jcf.2025.11.003_bib0002","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081545","article-title":"Diabetes in cystic fibrosis: multicenter screening results based on current guidelines","volume":"8","author":"Scheuing","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcf.2025.11.003_bib0003","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/pedi.13453","article-title":"ISPAD Clinical Practice Consensus Guidelines 2022: management of cystic fibrosis-related diabetes in children and adolescents","volume":"23","author":"Ode","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jcf.2025.11.003_bib0004","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1515\/jpem.2011.050","article-title":"Low-dose insulin therapy in patients with cystic fibrosis and early-stage insulinopenia prevents deterioration of lung function: a 3-year prospective study","volume":"24","author":"Kolou\u0161kov\u00e1","year":"2011","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.jcf.2025.11.003_bib0005","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/pedi.12094","article-title":"Importance of screening with oral glucose tolerance test for early diagnosis of cystic fibrosis-related diabetes mellitus","volume":"15","author":"Noronha","year":"2014","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jcf.2025.11.003_bib0006","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jcf.2019.07.010","article-title":"The association of pediatric cystic fibrosis-related diabetes screening on clinical outcomes by center: a CF patient registry study","volume":"19","author":"Franck Thompson","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2025.11.003_bib0007","first-page":"169","volume":"17","author":"Weiss","year":"2023","journal-title":"M\u00e9d Malad M\u00e9tabol"},{"key":"10.1016\/j.jcf.2025.11.003_bib0008","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jcjd.2018.04.008","article-title":"Cystic fibrosis-related diabetes screening in adults: a gap analysis and evaluation of accuracy of glycated hemoglobin levels","volume":"43","author":"Gilmour","year":"2019","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jcf.2025.11.003_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112578","article-title":"High variability in oral glucose tolerance among 1128 patients with cystic fibrosis: a multicenter screening study","volume":"9","author":"Scheuing","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcf.2025.11.003_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2024.06.009","article-title":"Feasibility and accuracy of at-home glucose tolerance tests for cystic fibrosis related diabetes screening","author":"Alexandre-Heymann","year":"2024","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2025.11.003_bib0011","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ando.2022.09.025","article-title":"Marginal association of fasting blood glucose with the risk of cystic fibrosis-related diabetes","volume":"84","author":"Potter","year":"2023","journal-title":"Ann Endocrinol"},{"key":"10.1016\/j.jcf.2025.11.003_bib0012","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jcf.2016.02.005","article-title":"Glycated hemoglobin cannot yet be proposed as a screening tool for cystic fibrosis related diabetes","volume":"15","author":"Boudreau","year":"2016","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2025.11.003_bib0013","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.diabet.2008.05.010","article-title":"No relationship between mean plasma glucose and glycated haemoglobin in patients with cystic fibrosis-related diabetes","volume":"34","author":"Godbout","year":"2008","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.jcf.2025.11.003_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2023.101455","article-title":"A glycosylated hemoglobin A1c above 6% (42 mmol\/mol) is associated with a high risk of developing cystic fibrosis-related diabetes and a lower probability of weight gain in both adults and children with cystic fibrosis","volume":"49","author":"Potter","year":"2023","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.jcf.2025.11.003_bib0015","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jcf.2015.03.013","article-title":"HbA1c as a screening tool for cystic fibrosis related diabetes","volume":"15","author":"Burgess","year":"2016","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2025.11.003_bib0016","article-title":"Cystic fibrosis related diabetes: a first canadian clinical practice guideline","author":"Coriati","year":"2024","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jcf.2025.11.003_bib0017","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1530\/EJE-09-1020","article-title":"Abnormal glucose tolerance in children with cystic fibrosis: the predictive role of continuous glucose monitoring system","volume":"162","author":"Schiaffini","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jcf.2025.11.003_bib0018","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jcf.2013.11.005","article-title":"Early assessment of glucose abnormalities during continuous glucose monitoring associated with lung function impairment in cystic fibrosis patients","volume":"13","author":"Leclercq","year":"2014","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2025.11.003_bib0019","article-title":"Comparison of continuous glucose monitoring to reference standard oral glucose tolerance test for the detection of dysglycemia in cystic Fibrosis: a systematic review","volume":"30","author":"Kumar","year":"2022","journal-title":"J Clin Transl Endocrinol"},{"key":"10.1016\/j.jcf.2025.11.003_bib0020","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2337\/dc10-1768","article-title":"Clinical care guidelines for cystic fibrosis\u2013related diabetes","volume":"33","author":"Moran","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcf.2025.11.003_bib0021","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.2337\/dc22-0534","article-title":"GlyCulator 3.0: a fast, easy-to-use analytical tool for CGM data analysis, aggregation, center benchmarking, and data sharing","volume":"46","author":"Chrzanowski","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcf.2025.11.003_bib0022","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1177\/19322968221085273","article-title":"A glycemia risk index (GRI) of hypoglycemia and hyperglycemia for continuous glucose monitoring validated by clinician ratings","volume":"17","author":"Klonoff","year":"2023","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.jcf.2025.11.003_bib0023","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1527932","article-title":"Glucose >200\u2009mg\/dL during continuous glucose monitoring identifies adult patients at risk for development of cystic fibrosis related diabetes","author":"Taylor-Cousar","year":"2016","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.jcf.2025.11.003_bib0024","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2025.2514787","article-title":"Time to replace the oral glucose tolerance test for cystic fibrosis related diabetes first-step screening? Establishing glycemic tools relevant to cystic fibrosis","volume":"57","author":"Estey","year":"2025","journal-title":"Ann Med"},{"key":"10.1016\/j.jcf.2025.11.003_bib0025","article-title":"Lack of association between hemoglobin a1c and continuous glucose monitor metrics among individuals with prediabetes and normoglycemia","author":"Rodriguez","year":"2025","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jcf.2025.11.003_bib0026","first-page":"1","article-title":"Feasibility of using continuous glucose monitoring to detect glycemic abnormalities in children with cystic fibrosis","author":"Leonard","year":"2024","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.jcf.2025.11.003_bib0027","article-title":"Clinical practice versus guidelines for the screening of cystic fibrosis-related diabetes: a French survey from the 47 centers","volume":"28","author":"Weiss","year":"2022","journal-title":"J Clin Transl Endocrinol"},{"key":"10.1016\/j.jcf.2025.11.003_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2024.108703","article-title":"Early glucose abnormalities revealed by continuous glucose monitoring associate with lung function decline in cystic fibrosis: a five-year prospective study","volume":"38","author":"Rakotoarisoa","year":"2024","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.jcf.2025.11.003_bib0029","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jcf.2018.03.008","article-title":"Continuous glucose monitoring abnormalities in cystic fibrosis youth correlate with pulmonary function decline","volume":"17","author":"Chan","year":"2018","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2025.11.003_bib0030","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1055\/s-2008-1062723","article-title":"Continuous glucose monitoring in cystic fibrosis patients according to the glucose tolerance","volume":"40","author":"Moreau","year":"2008","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.jcf.2025.11.003_bib0031","doi-asserted-by":"crossref","unstructured":"Predictive value of 1-Hour glucose elevations during oral glucose tolerance testing for cystic fibrosis-related diabetes - Lorenz - 2023 - Pediatric Diabetes - Wiley Online library n.d. https:\/\/onlinelibrary.wiley.com\/doi\/10.1155\/2023\/4395556 (Accessed 7 October 2025).","DOI":"10.1155\/2023\/4395556"},{"key":"10.1016\/j.jcf.2025.11.003_bib0032","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jcf.2015.03.001","article-title":"Characterization of patients with cystic fibrosis presenting an indeterminate glucose tolerance (INDET)","volume":"15","author":"Coriati","year":"2016","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2025.11.003_bib0033","doi-asserted-by":"crossref","first-page":"e3901","DOI":"10.1210\/clinem\/dgab384","article-title":"Combined indeterminate and impaired glucose tolerance is a novel group at high risk of cystic fibrosis-related diabetes","volume":"106","author":"Potter","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcf.2025.11.003_bib0034","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2337\/dc21-0602","article-title":"CGM metrics predict imminent progression to type 1 diabetes: autoimmunity screening for kids (ASK) study","volume":"45","author":"Steck","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcf.2025.11.003_bib0035","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.2337\/dc08-1925","article-title":"Validation of continuous glucose monitoring in children and adolescents with cystic fibrosis: a prospective cohort study","volume":"32","author":"O\u2019Riordan","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcf.2025.11.003_bib0036","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jpeds.2005.05.004","article-title":"Continuous glucose monitoring in adolescents with cystic fibrosis","volume":"147","author":"Jefferies","year":"2005","journal-title":"J. Pediatr."},{"key":"10.1016\/j.jcf.2025.11.003_bib0037","doi-asserted-by":"crossref","first-page":"e1444","DOI":"10.1210\/clinem\/dgab857","article-title":"Continuous glucose monitoring and HbA1c in cystic fibrosis: clinical correlations and implications for CFRD diagnosis","volume":"107","author":"Scully","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcf.2025.11.003_bib0038","doi-asserted-by":"crossref","first-page":"e548","DOI":"10.1210\/clinem\/dgab692","article-title":"The relationship between continuous glucose monitoring and OGTT in youth and young adults with cystic fibrosis","volume":"107","author":"Chan","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcf.2025.11.003_bib0039","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1080\/02713683.2024.2333770","article-title":"Glycemic variability and the thickness of retinal layers in cystic fibrosis patients with and without cystic fibrosis related diabetes","volume":"49","author":"Saegebrecht","year":"2024","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.jcf.2025.11.003_bib0040","doi-asserted-by":"crossref","DOI":"10.1002\/ppul.71267","article-title":"Utility of continuous glucose monitors for improved detection of cystic fibrosis-related diabetes","volume":"60","author":"Moore","year":"2025","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2025.11.003_bib0041","doi-asserted-by":"crossref","first-page":"4763","DOI":"10.1038\/s41598-019-40592-9","article-title":"Glucose tolerance in Canadian and French cystic fibrosis adult patients","volume":"9","author":"Reynaud","year":"2019","journal-title":"Sci Rep"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199325024993?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199325024993?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T11:36:11Z","timestamp":1781782571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199325024993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1569199325024993"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2025.11.003","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Continuous glucose monitoring is a better indicator of glucose tolerance than HbA1c in cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2025.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}